Each month Caring Cross provides free webinars discussing the latest research and technology in cell and gene therapy. A short Q&A session will follow the discussion. Registration is required for all participants.
All webinars occur on Fridays at 3:00pm (EST) and can be accessed online after registration. Webinars are archived and are available online.
Upcoming Events
Thank you for registering! Please check your email for confirmation, and add this event to your calendar. Double-check Spam or Promotions just in case it landed there.
Access to a webinar link will be provided the day of this event.
While you’re waiting? Follow us on Twitter for updates.
Non Member
Technology Education
Broadening Access to Genetic Medicine
Kevin Curran, PhD
Past Events
Thank you for registering! Please check your email for confirmation, and add this event to your calendar. Double-check Spam or Promotions just in case it landed there.
Access to a webinar link will be provided the day of this event.
While you’re waiting? Follow us on Twitter for updates.
Non Member
Technology Education
AI and drug design
Kevin Curran, PhD
Scientific Seminar
Nothing About Us Without Us: Challenges and Opportunities for Engaging Communities in the Development of Gene Therapies in Resource-Limited Settings
Michael Louella
Technology Education
AI Applications in Target Discovery
Kevin Curran, PhD
Scientific Seminar
Aberrantly spliced tumor epitopes: lost and found
Andrei Thomas-Tikhonenko, PhD
Technology Education
Commercial Challenges for Gene Editing (including manufacturing and patient access)
Kevin Curran, PhD
Scientific Seminar
CAR T Cell Targeting and Enhancements
Avery D. Posey, Jr, PhD
Technology Education
Clinical advances/challenges with GEx (Intellia, Verve, Beam…)
Kevin Curran, PhD
Scientific Seminar
Beyond Efficacy: Safety and Access Issues in Lentiviral Gene Therapy
Kenneth Cornetta
Technology Education
Non-viral vs. viral delivery for GEx (LNP, VLP, electroporation)
Kevin Curran, PhD
Scientific Seminar
If we build it, they will come…except if they can’t: strategies to enhance access to gene-modified cell therapies
Dr. Rayne Rouce
